Related Experiment Video
Updated: Mar 16, 2026

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
Published on: March 24, 2023
Pred-hERG: A Novel web-Accessible Computational Tool for Predicting Cardiac Toxicity.
Rodolpho C Braga1,2, Vinicius M Alves1, Meryck F B Silva1
1Labmol - Laboratory for Molecular Modeling and Drug Design, Faculty of Pharmacy, Federal University of Goias, Goiania, Goiás 74605-170, Brazil phone: +55 62 3209-6451; fax: +55 62 3209-6037.
This study introduces Pred-hERG, a free web server for identifying potential hERG channel blockers early in drug development. It uses a large dataset and robust models to predict cardiac arrhythmia risks.
Area of Science:
- Cardiovascular Pharmacology
- Computational Chemistry
- Drug Discovery
Background:
- Blockage of the hERG K(+) channel is a significant cause of lethal cardiac arrhythmia.
- The hERG channel's ligand promiscuity makes it a critical antitarget in early drug development.
- Identifying potential hERG blockers early is crucial to mitigate cardiac risks.
Purpose of the Study:
- To develop an innovative and freely accessible web server for the early identification of hERG channel blockers and non-blockers.
- To provide a tool for screening chemical libraries and assessing potential cardiac risks associated with drug candidates.
Main Methods:
- Compiled the largest publicly available curated hERG dataset, comprising 5,984 compounds.
- Developed robust and externally predictive binary and multiclass computational models for hERG channel interaction.
- Integrated these models into a user-friendly web service.
Main Results:
- Achieved a high predictive performance with a binary classification model (CCR≈0.8) and a multiclass model (accuracy≈0.7).
- The developed web server, Pred-hERG, offers predictions from both binary and multiclass models.
- Provides probability maps of atomic contributions to aid in understanding prediction rationale.
Conclusions:
- The Pred-hERG web server is a valuable, freely accessible resource for early-stage drug development.
- Facilitates the identification of potential hERG blockers, thereby reducing the risk of drug-induced cardiac arrhythmia.
- The platform is designed for continuous updates and improvements as new data becomes available.
More Related Videos
10:39Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening
Published on: April 15, 2017
08:03Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
Published on: October 20, 2022
Related Concept Videos
Drug Toxicity: Risk factors
Cardiomyopathy III: Hypertrophic Cardiomyopathy